13D/13G Filings - Immune Therapeutics Inc. (IMUN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-12-15
4:48 pm
Purchase
2022-07-25 13D Immune Therapeutics, Inc.
IMUN
Salomonsky Henry Louis 12,168,900
14.700%
12,168,900increase
(New Position)
Filing
History
2021-06-07
07:06 am
Purchase
2021-05-28 13D Immune Therapeutics, Inc.
IMUN
Griffin Noreen 59,877
12.400%
59,877increase
(New Position)
Filing
History
2020-06-25
8:26 pm
Unchanged
2020-06-25 13G Immune Therapeutics, Inc.
IMUN
Ahmetaj Erjon 22
4.880%
0
(Unchanged)
Filing
History
2020-05-18
6:10 pm
Sale
2020-05-18 13G Immune Therapeutics, Inc.
IMUN
Iliad Research & Trading, L.P. 46
9.990%
-45,467decrease
(-99.90%)
Filing
History